CVSA Covista (CVSA) Q3 FY26 earnings call
Covista reported strong Q3 FY26 results, driven by a successful turnaround at Chamberlain and sustained momentum at Walden, leading to record enrollments. Management raised full-year guidance for both revenue and adjusted EPS, citing operational improvements and robust demand for healthcare education. The company emphasized its strong financial foundation and disciplined capital allocation, including debt refinancing and share repurchases, while investing in strategic growth initiatives like AI and campus expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
CVSA operating KPIs by quarter
| KPI | This call Mar 2026 Q3 FY26 | Jun 2026 Q4 FY26 | Change vs prior quarter |
|---|---|---|---|
| Total student enrollment Walden | 54.474KTotal student enrollment grew 12.3% to 54,474 students joining Chamberlain and also setting a record this quarter and marking Walden's 11th consecutive quarter of total enrollment growth.Source: earnings call transcript | <55KTotal student enrollment was up 14% to nearly 55,000 students, our 12th consecutive quarter of growth and the highest total enrollment in Walden's history with strength across health care and non-health care programs.Source: earnings call transcript | — |
| Total student enrollment Medical and Veterinary | 5,344Total student enrollment increased 4.1% to 5,344 students with growth in both our medical and veterinary programs.Source: earnings call transcript | 5,100+Total student enrollment was up 7.3% to over 5,100 students, led by medical with new enrollment accelerating at both Med and Vet.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.